Physician profile
Kara-Lee Pool
NPI 1508025289
$29,436.65
in general payments reported to CMS, 2019-2025
8 companies · $5,429 in 2025
The $5,429 reported for 2025 was more than what 95% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.78 · 2020: $26.57 · 2023: $78.07 · 2024: $24K · 2025: $5,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $2,386 · Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,281.25 |
| Travel and Lodging | $2,386.45 |
| Food and Beverage | $708.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $21,734.50 | 2023-2025 | Encor |
| Guerbet LLC | $7,200.00 | 2024 | Elucirem |
| Stryker Corporation | $218.66 | 2025 | Molli |
| Rti Surgical, INC | $92.35 | 2025 | |
| Hologic Sales and Service, LLC | $69.45 | 2025 | Magtrace, Magseed, 3dimensions |
| Philips North America LLC | $44.15 | 2023 | |
| Siemens Medical Solutions USA, INC. | $43.76 | 2020-2025 | Mammomat B.Brilliant |
| Ekos Corporation | $33.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara-Lee Pool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.